Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/17/1999WO1999015179A8 Methods of limiting apoptosis of cells
06/17/1999WO1999010292A3 Robustaflavone, intermediates and analogues and method for preparation thereof
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1999007695A3 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
06/17/1999WO1999004769A8 Use of aminoacridines for the treatment of solid tumours, metastases and lymphomas
06/17/1999WO1998055075A3 Compositions and methods for inhibiting photoaging of skin
06/17/1999DE19755268A1 Benzamidinderivate Benzamidine derivatives
06/17/1999DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999DE19754795A1 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999CA2314433A1 Use of alpha-glucosidase inhibitors for treating high-risk impaired glucose tolerance
06/17/1999CA2314408A1 Antiviral compounds
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313626A1 Methods and compositions for treating diabetes
06/17/1999CA2313390A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2313236A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides, corresponding acids, and uses
06/17/1999CA2313191A1 Novel antiarrhythmic compounds
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312987A1 Selective .beta.3 adrenergic agonists
06/17/1999CA2312965A1 (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chlorophenyl|-1h-pyrazol-4-yl|-2-¬(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl|-prop-2-enoic acid monoargininyl salt
06/17/1999CA2312889A1 Adamantane derivatives
06/17/1999CA2312849A1 Selective .beta.3 adrenergic agonists
06/17/1999CA2312844A1 Pharmaceuticals
06/17/1999CA2312760A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/17/1999CA2312731A1 Creams containing vitamin d3 derivatives
06/17/1999CA2312720A1 Retinoic acid mimetic anilides
06/17/1999CA2312716A1 Medicament for prevention and treatment of diabetes
06/17/1999CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999CA2312423A1 Inhibition of membrane-associated viral replication
06/17/1999CA2312420A1 Adamantane derivatives
06/17/1999CA2312419A1 Novel compounds
06/17/1999CA2312357A1 Novel compounds
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999CA2312006A1 Nucleic acid mediated rna tagging and rna revision
06/17/1999CA2311722A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners
06/17/1999CA2309686A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them
06/17/1999CA2309026A1 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones
06/16/1999EP0922705A1 Fluorinated Cephalosporin antibiotics for treatment of mastitis
06/16/1999EP0922703A1 Substituted heterocyclic benzocycloalkenes and their use as analgesically active compounds
06/16/1999EP0922702A1 Azulene derivatives and pharmaceutical compositions containing them
06/16/1999EP0922697A1 Substituted Pyrazolyl benzenesulfonamides and their use as cyclooxygenase II inhibitors
06/16/1999EP0922463A2 Process for preparation of solid dosage forms
06/16/1999EP0922461A1 Remedies for hyperphosphatemia
06/16/1999EP0922460A1 Neuro-Function regulatory agent comprising glycosyl vitamin P
06/16/1999EP0922459A1 Pharmaceutical compositions comprising D-galactose and the use thereof
06/16/1999EP0922458A1 Potentiation of temozolomide by an ATase inhibitor
06/16/1999EP0922457A1 Skin protection composition
06/16/1999EP0922456A1 Skin rash prevention composition
06/16/1999EP0922455A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
06/16/1999EP0922454A2 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
06/16/1999EP0922453A2 Percutaneous absorption type preparation containing tulobuterol
06/16/1999EP0922452A1 Skin care composition
06/16/1999EP0922448A2 A humectant and an endermic liniment
06/16/1999EP0922114A2 Catalytic nucleic acid and its medical use
06/16/1999EP0922071A1 Polycarboxylic based cross-linked copolymers
06/16/1999EP0922061A2 Polymerisates of unsaturated saccharide acids and their derivatives, copolymerisates thereof with ethylenically unsaturated compounds and method for preparing the same
06/16/1999EP0922054A1 Anticoagulant peptidyl-arginine aldehyde derivatives
06/16/1999EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
06/16/1999EP0922050A1 3-descladinose-2,3-anhydroerythromycin derivatives
06/16/1999EP0922045A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
06/16/1999EP0922044A1 Pyrrolo(3,2-c) quinoline derivatives
06/16/1999EP0922042A1 Novel piperazine containing compounds
06/16/1999EP0922039A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists
06/16/1999EP0922036A1 Arylalkanoyl pyridazines
06/16/1999EP0922035A1 Tetrahydroisoquinoline derivatives and their pharmaceutical use
06/16/1999EP0922034A1 Tetrahydroquinoline derivatives as eaa antagonists
06/16/1999EP0922033A1 Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative
06/16/1999EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives
06/16/1999EP0922029A1 Ether muscarinic antagonists
06/16/1999EP0922028A1 Inhibitors of phospholipase enzymes
06/16/1999EP0921822A1 Animal model for transplantation
06/16/1999EP0921821A1 2-methoxyestradiol-induced apoptosis in cancer cells
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921811A2 Administration of histamine for therapeutic purposes
06/16/1999EP0921809A1 Use of prolactin as a tgf-beta antagonist
06/16/1999EP0921807A1 Hydrogenous medicament
06/16/1999EP0921806A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
06/16/1999EP0921804A1 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen
06/16/1999EP0921803A1 Methods for preventing and treating pestivirus infection and associated diseases
06/16/1999EP0921802A1 Method for treating pain
06/16/1999EP0921801A1 Inhibitors of farnesyl-protein transferase
06/16/1999EP0921800A1 Substituted biphenyl isoxazole sulfonamides
06/16/1999EP0921799A1 Methods of inhibiting colon tumors
06/16/1999EP0921798A1 Novel treatment of leptine resistance
06/16/1999EP0921797A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
06/16/1999EP0921796A1 Tetrahydrolipstatin containing compositions
06/16/1999EP0921795A1 An aqueous formulation comprising bambuterol and the use thereof
06/16/1999EP0921794A1 Amino acid composition and use thereof in treating tumor growth and metastasis
06/16/1999EP0921793A1 Solid, non-deliquescent formulations of sodium valproate
06/16/1999EP0921792A1 Biocidal compositions
06/16/1999EP0921791A1 Composition comprising mupirocin and chlorhexidine
06/16/1999EP0921790A1 Sulfonyl fluorides for the treatment of alzheimer's disease
06/16/1999EP0921789A1 Taste masked liquid suspensions
06/16/1999EP0921787A1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
06/16/1999EP0921786A1 Nasal administration of desmopressin
06/16/1999EP0921785A1 Combination of acid protease enzymes and acidic buffers and uses thereof
1 ... 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 ... 7860